Table 1 |
|
| Inclusion and exclusion criteria | |
| Inclusion Criteria: | |
| · Must be 18 years of age or older | |
| · Diagnosed with Type 1 or Type 2 diabetes | |
| · Recent HbA1c #62;7.5% (measured within the last 6 weeks at local laboratory) | |
| · Using MDI therapy for at least 6 months consisting of 1–2 injections per day of long-acting basal insulin (Lantus® or Detemir®) and at least 2 injections per day of regular or rapid-acting analog insulin for meal coverage | |
| · Participant adjusts meal insulin doses based on carbohydrate content of meals | |
| · Participant with Type 2 diabetes may be on stable metformin therapy (therapy unchanged during 3 months prior to study) | |
| · Participant has been in Investigator's practice for at least 3 months; however may have been seen by another physician in the practice | |
| · Participant has completed carbohydrate (CHO) training within the last 2 years | |
| Exclusion Criteria: | |
| · On a therapy regimen that conflicts with study: | |
| · NPH or pre-mixed insulin | |
| · Oral anti-diabetic agents, with the exception of metformin | |
| · Injectable anti-diabetic agents other than long-acting insulin and rapid-acting insulin analogs or regular insulin (e.g., fixed dose therapy) | |
| · Use of sliding scale insulin therapy that determines insulin dosages based exclusively on specific bG results | |
| · Participated in another interventional trial within 6 weeks prior to study | |
| · Diagnosed with any clinically significant infectious disease or major organ system disease, such as gastroparesis or renal disease (at Investigator's discretion) | |
| · Used systemic oral or inhaled steroids for more than 7 days within the last 3 months | |
| · On Chemotherapy or Radiation therapy (self-reported) | |
| · Pregnant or lactating or is currently planning a pregnancy |
Cavan et al. BMC Family Practice 2012 13:102 doi:10.1186/1471-2296-13-102
